These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20890918)

  • 1. Long-term results of surgery for lithium-associated hyperparathyroidism (Br J Surg 2010; 97:1680-1685).
    Varhaug JE
    Br J Surg; 2010 Nov; 97(11):1685-6. PubMed ID: 20890918
    [No Abstract]   [Full Text] [Related]  

  • 2. Lithium hypercalcemia, hyperparathyroidism, and cinacalcet.
    Gregoor PS; de Jong GM
    Kidney Int; 2007 Mar; 71(5):470. PubMed ID: 17315015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic agents for disorders of bone and calcium metabolism. The calcimimetic cinacalcet HCl].
    Nakanishi S; Fukagawa M
    Clin Calcium; 2007 Jan; 17(1):88-92. PubMed ID: 17211098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of calcimimetics].
    Nishi H; Fukagawa M
    Clin Calcium; 2004 May; 14(5):756-9. PubMed ID: 15577038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic and clinical aspects of calcimimetics. The clinical effect and usefulness of Cinacalcet as a calcimimetics on three CKD-5D patients undergoing hemodialysis with refractory secondary hyperparathyroidism].
    Hanba Y; Ooura M; Negi S; Shigematsu T
    Clin Calcium; 2008 Jan; 18(1):81-8. PubMed ID: 18175876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium receptor/calcium-sensing receptor].
    Nagano N
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):188-90. PubMed ID: 17139821
    [No Abstract]   [Full Text] [Related]  

  • 7. 19th Annual Meeting of the Japanese Society for Kidney Bone Disease.
    Akizawa T
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S1. PubMed ID: 19032519
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of secondary hyperparathyroidism].
    Cunningham J
    Clin Calcium; 2005 Sep; 15 Suppl 1():217-24. PubMed ID: 16279027
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism.
    Nagano N
    Pharmacol Ther; 2006 Mar; 109(3):339-65. PubMed ID: 16102839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism].
    Vestergaard P; Nielsen LR; Mosekilde L
    Ugeskr Laeger; 2006 Jan; 168(1):29-32. PubMed ID: 16393559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic and clinical aspects of calcimimetics. Cinacalcet, effect and mechanisms of action].
    Nakanishi S; Fukagawa M
    Clin Calcium; 2008 Jan; 18(1):20-6. PubMed ID: 18175867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic and clinical aspects of calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation].
    Komaba H; Fukagawa M
    Clin Calcium; 2008 Jan; 18(1):60-6. PubMed ID: 18175873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride.
    Sloand JA; Shelly MA
    Am J Kidney Dis; 2006 Nov; 48(5):832-7. PubMed ID: 17060004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of calcimimetics in hyperparathyroidism.
    Peacock M
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):414-5. PubMed ID: 15758287
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cinacalcet - an allosteric enhancer at the Ca2+-receptor].
    Kebig A; Mohr K
    Dtsch Med Wochenschr; 2008 Aug; 133(33):1681-3. PubMed ID: 18661462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
    Filopanti M; Verga U; Ermetici F; Olgiati L; Eller-Vainicher C; Corbetta S; Persani L; Beck-Peccoz P; Spada A
    Eur J Endocrinol; 2012 Aug; 167(2):157-64. PubMed ID: 22577108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism.
    Padmanabhan H
    South Med J; 2010 Mar; 103(3):272-5. PubMed ID: 20134376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials.
    Goodman WG
    Pediatr Nephrol; 2003 Dec; 18(12):1206-10. PubMed ID: 14586685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parathyroid and bone. Calcimimetics and bone metabolism].
    Fukumoto S
    Clin Calcium; 2007 Dec; 17(12):1865-9. PubMed ID: 18057662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcimimetics--fooling the calcium receptor.
    Ritz E
    Pediatr Nephrol; 2005 Jan; 20(1):15-8. PubMed ID: 15517414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.